분당서울대학교병원에 찾아오시는 길입니다.
우)13620, 경기도 성남시 분당구 구미로173번길 82
분당서울대학교병원의 공지사항을 알려드립니다.
다양하고 유익한 건강상식을 제공해 드립니다.
진료시간표
요일 | 월 | 화 | 수 | 목 | 금 | 토 |
---|---|---|---|---|---|---|
오전 | ![]() |
![]() |
||||
오후 | ![]() |
안녕하세요?
분당서울대학교병원 소화기내과 이종찬A 입니다.
췌장과 담도/담낭의 질환은 전통적으로 진단과 치료가 쉽지 않은 분야이나, 최근 가장 발전이 가장 빠른 분야이기도 합니다.
특히 췌장암, 담관암, 담낭암은 사망률이 매우 높은 암종이었으나 최근 각종 치료 기법의 발달로 적극적인 치료가 가능하며 평균 생존기간이 점차 증가하고 있는 질환으로, 이에 기여하기 위하여 연구, 진료, 교육에 최선을 다하고 있습니다.
늘 가족같은 마음으로 환자분의 치료와 존엄한 삶을 위하여 노력하겠습니다.
감사합니다.
진단 내시경초음파 검사 후에는 금식을 유지할 필요가 없으나 세침흡인술 이후에는 시술 당일 금식을 유지하게 됩니다.
Kim J, Ji E, Jung K, Jung IH, Park J, Lee JC*, Kim JW, Hwang JH, Kim J.
Gender differences in patients with metastatic pancreatic cancer who received folfirinox.
J Pers Med. 2021 Jan 30;11(2):83.
2021 ; PMID_33573202
Song DH, Cho IK, Shin DW, Lee JC*, Cho JY, Yoon YS, Hwang JH, Han HS, Kim J.
The clinical significance of preoperative C-reactive protein/albumin ratio in patients with resected extrahepatic bile duct cancer.
Sci Rep. 2020 Dec 3;10(1):21552.
2021 ; PMID_33273671
Cancers (Basel). 2020 Oct 27;12(11):3137. PMID: 33120908
Jung JH, Shin DW, Kim J, Lee JC*, Hwang JH.
Primary Granulocyte Colony-Stimulating Factor Prophylaxis in Metastatic Pancreatic Cancer Patients Treated with FOLFIRINOX as the First-Line Treatment.
2020 ;(PMID 33573202)
Sci Rep. 2020 Oct 5;10(1):16518. PMID: 33020506
Youn Y, Lee JC*, Kim J, Kim JH, Hwang JH.
Cdc6 disruption leads to centrosome abnormalities and chromosome instability in pancreatic cancer cells.
2020 ;(PMID: 33573202)
PLoS One. 2020 Sep 16;15(9):e0238649. PMID: 32936836
Lee J, Lee JC*, Kim HW, Kim J, Hwang JH.
Postoperative muscle mass restoration as a prognostic factor in patients with resected pancreatic cancer.
2020 ;(PMID_33573202)
J Cancer. 2020 Jul 25;11(19):5601-5611. PMID: 32913455
Kim JH, Youn Y, Lee JC*, Kim J, Hwang JH.
Involvement of the NF-κB signaling pathway in proliferation and invasion inhibited by Zwint-1 deficiency in Pancreatic Cancer Cells
2020
Am J Clin Oncol. 2020 Sep;43(9):654-659. PMID: 32889836
Lee JC*, Woo SM, Shin DW, Kim J, Yang SY, Kim MJ, Kim JW, Kim JW, Lee WJ, Cha HS, Park P, Kim J, Hwang JH.
Comparison of FOLFIRINOX and Gemcitabine Plus Nab-paclitaxel for Treatment of Metastatic Pancreatic Cancer: Using Korean Pancreatic Cancer (K-PaC) Registry.
2020
Pancreatology. 2020 Oct;20(7):1465-1471. PMID: 32873483
Chung KH, Lee JC*, Lee J, Cho IK, Kim J, Jang W, Yoo BC, Hwang JH.
Serum fibrinogen as a diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma.
2020
J Hepatobiliary Pancreat Sci. 2020 Oct;27(10):690-699. PMID: 32713115
Cho JH, Yoon YS, Kim EJ, Kim YS, Cho JY, Han HS, Park YH, Shin DW, Lee JC*, Hwang JH, Kim J.
A multicenter prospective randomized controlled trial for preoperative biliary drainage with uncovered metal versus plastic stents for resectable periampullary cancer.
2020
Sci Rep. 2020 Jul 23;10(1):12348. PMID: 32704067 (*Co-first)
Ahn S, Lee JC*, Shin DW, Kim J, Hwang JH.
High PD-L1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer.
2020
Am J Clin Oncol. 2020 Jun;43(6):422-427. PMID: 32118610.
Shin DW, Kim MJ, Lee JC*, Kim J, Woo SM, Lee WJ, Lee KH, Hwang JH.
Gemcitabine Plus Cisplatin Chemotherapy Prolongs the Survival in Advanced Hilar Cholangiocarcinoma: A Large Multicenter Study.
2020
Gastrointest Endosc. 2020 Nov;92(5):1044-1052.e1. PMID: 32084409
Lee JC*, Shin DW, Park H, Kim J, Youn Y, Kim JH, Kim J, Hwang JH.
Tolerability and safety of EUS-injected adenovirus-mediated double-suicide gene therapy with chemotherapy in locally advanced pancreatic cancer: a phase 1 trial.
2020
Gut Liver. 2020 Nov 15;14(6):833-841. PMID: 31826361
Park JM, Kang CD, Lee JC*, Hwang JH, Kim J.
Recent 5-Year Trend of Endoscopic Retrograde Cholangiography in Korea Using National Health Insurance Review and Assessment Service Open Data.
2020
Gut Liver. 2020 Jul 15;14(4):521-528. PMID: 31615191
Cho IK, Kim H, Lee JC*, Lee J, Kim J, Ahn S, Park H, Hwang JH.
Higher Tumor Cellularity in Resected Pancreatic Ductal Adenocarcinoma Is a Negative Prognostic Indicator.
2020
Dig Dis Sci. 2020 Jan;65(1):86-95. PMID: 31549335
Jang ES, Park SM, Park YS, Lee JC*, Kim N.
Work-Life Conflict and Its Health Effects on Korean Gastroenterologists According to Age and Sex.
2020
Sci Rep. 2019 Oct 30;9(1):15662. PMID: 31666626 (*Co-first)
Lee YS, Lee JC*, Yang SY, Kim J, Hwang JH.
Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer according to intention-to-treat and per-protocol analysis: A systematic review and meta-analysis.
2019
World J Gastroenterol. 2019 Oct 7;25(37):5619-5629. PMID: 31602162
Hwang YJ, Park SM, Ahn S, Lee JC*, Park YS, Kim N.
Accuracy of an administrative database for pancreatic cancer by international classification of disease 10 th codes: A retrospective large-cohort study.
2019
Pathol Int. 2019 Jul;69(7):420-426. PMID: 31219205
Ahn S, Lee JC*, Hwang JH, Yoon YS, Lee KH, Zen Y.
Duct-obstructive pancreatitis with granulocytic epithelial lesion in a patient with ulcerative colitis: An atypical manifestation of type 2 autoimmune pancreatitis?
2019
Eur J Surg Oncol. 2019 Nov;45(11):2159-2165. PMID: 31202572
Shin DW, Lee JC*, Kim J, Woo SM, Lee WJ, Han SS, Park SJ, Choi KS, Cha HS, Yoon YS, Han HS, Hong EK, Hwang JH.
Validation of the American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinoma.
2019
Histopathology. 2019 Oct;75(4):526-536. PMID: 31081949
Ahn S, Lee Y, Kim JW, Lee JC*, Hwang JH, Yoon YS, Cho JY, Han HS, Choi Y, Kim H.
Programmed cell death ligand-1 (PD-L1) expression in extrahepatic biliary tract cancers: a comparative study using 22C3, SP263 and E1L3N anti-PD-L1 antibodies.
2019
Medicine (Baltimore). 2018 Dec;97(50):e13592. PMID: 30558029
Lee J, Lee JC*, Gromski MA, Kim HW, Kim J, Kim J, Hwang JH.
Clinical outcomes of FOLFIRINOX in locally advanced pancreatic cancer: A single center experience.
2018
PLoS One. 2018 Dec 17;13(12):e0209104. PMID: 30557411
Kim J, Kim H, Lee JC*, Kim JW, Paik WH, Lee SH, Hwang JH, Ryu JK, Kim YT.
Human equilibrative nucleoside transporter 1 (hENT1) expression as a predictive biomarker for gemcitabine chemotherapy in biliary tract cancer.
2018
J Dig Dis. 2018 Oct;19(10):605-613. PMID: 30126061
Lee JC*, Kim JS, Kim HW, Cho IK, Lee J, Jang ES, Lee SH, Hwang JH, Kim JW, Jeong SH, Kim J.
Outcome of endoscopic retrograde cholangiopancreatography in patients with clinically defined decompensated liver cirrhosis.
2018
Hepatobiliary Pancreat Dis Int. 2018 Dec;17(6):553-558. PMID: 30122329
Lee JC*, Kim H, Kim HW, Lee J, Paik KH, Kang J, Hwang JH, Kim J.
It is necessary to exam bottom and top slide smears of EUS-FNA for pancreatic cancer.
2018
BMJ Open. 2018 Apr 9;8(4):e017249. PMID: 29632079
Lee JC*, Ahn S, Cho IK, Lee J, Kim J, Hwang JH.
Management of recurrent pancreatic cancer after surgical resection: a protocol for systematic review, evidence mapping and meta-analysis.
2018
Eur J Cancer. 2017 May;76:125-133. PMID: 28324747
Lee JC*, Kim JW, Ahn S, Kim HW, Lee J, Kim YH, Paik KH, Kim J, Hwang JH.
Optimal dose reduction of FOLFIRINOX for preserving tumour response in advanced pancreatic cancer: Using cumulative relative dose intensity.
2017
PLoS One. 2017 Mar 16;12(3):e0173960. PMID: 28301556
Kim HW, Lee JC*, Lee J, Kim JW, Kim J, Hwang JH.
Early versus delayed initiation of adjuvant treatment for pancreatic cancer.
2017
Surgery. 2017 Jun;161(6):1579-1587. PMID: 28237643
Kim HW, Lee JC*, Paik KH, Kang J, Kim YH, Yoon YS, Han HS, Kim J, Hwang JH.
Adjunctive role of preoperative liver magnetic resonance imaging for potentially resectable pancreatic cancer.
2017
J Neurogastroenterol Motil. 2017 Apr 30;23(2):229-236. PMID: 28163259
Shim YK, Kim N, Park YH, Lee JC*, Sung J, Choi YJ, Yoon H, Shin CM, Park YS, Lee DH.
Effects of Age on Esophageal Motility: Use of High-resolution Esophageal Impedance Manometry.
2017
Medicine (Baltimore). 2017 Feb;96(5):e5926. PMID: 28151872
Kim HW, Lee JC*, Paik KH, Kang J, Kim J, Hwang JH.
Serum interleukin-6 is associated with pancreatic ductal adenocarcinoma progression pattern.
2017
Gut Liver. 2017 Mar 15;11(2):209-215. PMID: 27840366
Yoon K, Kim N, Kim J, Lee JW, Lee HS, Lee JC*, Yoon H, Shin CM, Park YS, Ahn SH, Park DJ, Kim HH, Lee YJ, Lee KH, Kim YH, Lee DH.
Dynamic Changes in Helicobacter pylori Status Following Gastric Cancer Surgery.
2017
Gastrointest Endosc. 2017 Feb;85(2):357-364. PMID: 27566055
Choi JH, Kim HW, Lee JC*, Paik KH, Seong NJ, Yoon CJ, Hwang JH, Kim J.
Percutaneous transhepatic versus EUS-guided gallbladder drainage for malignant cystic duct obstruction.
2017
Digestion. 2016;94(2):100-105. doi: 10.1159/000448917. PMID: 27640085
Kang J, Paik KH, Lee JC*, Kim HW, Lee J, Hwang JH, Kim J.
The Efficacy of Clinical Predictors for Patients with Intermediate Risk of Choledocholithiasis.
2016
Gut Liver. 2016 Sep 15;10(5):749-56. PMID: 27172930
Choi YJ, Kim N, Lee JY, Nam RH, Suh JH, Lee SM, Ham MH, Jo HJ, Shim YK, Park YH, Lee JC*, Choi YJ, Lee HS, Lee DH.
PMK-S005 Alleviates Age-Related Gastric Acid Secretion, Inflammation, and Oxidative Status in the Rat Stomach.
2016
Medicine (Baltimore). 2016 Apr;95(17):e3472. PMID: 27124043
Lee JC*, Ro YS, Cho J, Park Y, Lee JH, Hwang JH, Choi HJ, Lee S.
Characteristics of Venous Thromboembolism in Pancreatic Adenocarcinoma in East Asian Ethnics: A Large Population-Based Observational Study.
2016
Medicine (Baltimore). 2016 Apr;95(15):e3157. PMID: 27082555
Paik KH, Lee JC*, Kim HW, Kang J, Lee YS, Hwang JH, Ahn SH, Park DJ, Kim HH, Kim J.
Risk Factors for Gallstone Formation in Resected Gastric Cancer Patients.
2016
BMJ Open. 2016 Mar 25;6(3):e010491. PMID: 27016245
Lee JC*, Ahn S, Paik KH, Kim HW, Kang J, Kim J, Hwang JH.
Clinical impact of neoadjuvant treatment in resectable pancreatic cancer: a systematic review and meta-analysis protocol.
2016
Medicine (Baltimore). 2015 Dec;94(50):e2224. PMID: 26683934
Lee YS, Kim H, Kim HW, Lee JC*, Paik KH, Kang J, Kim J, Yoon YS, Han HS, Sohn I, Cho J, Hwang JH.
High Expression of MicroRNA-196a Indicates Poor Prognosis in Resected Pancreatic Neuroendocrine Tumor.
2015
Medicine (Baltimore). 2015 Oct;94(41):e1666. PMID: 26469901
Lee YS, Paik KH, Kim HW, Lee JC*, Kim J, Hwang JH.
Comparison of Endoscopic Ultrasonography, Computed Tomography, and Magnetic Resonance Imaging for Pancreas Cystic Lesions.
2015
Medicine (Baltimore). 2015 Jun;94(25):e1012. PMID: 26107667
Kim HW, Lee JC*, Paik KH, Lee YS, Hwang JH, Kim J.
Initial Metastatic Site as a Prognostic Factor in Patients With Stage IV Pancreatic Ductal Adenocarcinoma.
2015
Cancer Res Treat. 2014 Apr;46(2):194-9. PMID: 24851112
Cho J, Park Y, Lee JC*, Jung WJ, Lee S.
Case series of different onset of skin metastasis according to the breast cancer subtypes.
2014
Prim Care Respir J. 2013 Jun;22(2):149-54. PMID: 23494188
Lee JC*, Hwang HJ, Park YH, Joe JH, Chung JH, Kim SH.
Comparison of severity predictive rules for hospitalised nursing home-acquired pneumonia in Korea: a retrospective observational study.
2013
Cancer Res Treat. 2013 Jun;45(2):145-9. PMID: 23864848
Lim S, Han J, Park KH, Jung WJ, Lee YK, Choi A, Kim YJ, Lee JC*, Choi HJ.
Two cases of humoral hypercalcemia of malignancy in metastatic cholangiocarcinoma.
2013
Clin Chim Acta. 2013 Jun 5;421:226-9. PMID: 23454473
Kim SH, Chung JH, Lee JC*, Park YH, Joe JH, Hwang HJ.
Carboxy-terminal provasopressin may predict prognosis in nursing home acquired pneumonia.
2013
번호 | 매체명 | 제목 | 발간일 |
---|---|---|---|
60 | 디지틀조선일보 | 국내 연구팀, 차세대 의학 문헌 검색 엔진 ‘이비스’ 개발 | 2023-03-30 |
59 | 데일리메디 | 차세대 의학연구 검색엔진 ‘이비스’ 등장 | 2023-03-30 |
58 | 스포츠조선 | 분당서울대병원 융합연구팀, 차세대 의학연구 검색엔진 '이비스' 개발 | 2023-03-30 |
57 | 의약뉴스 | 충남대학교병원 운영 충청남도 공공보건의료지원단, 공공보건의료 돌봄 업무협... | 2023-03-30 |
56 | 라포르시안 | 분당서울대병원, 의학·생명과학 문헌 검색엔진 '이비스' 개발 | 2023-03-30 |
55 | 메디컬투데이 | 분당서울대병원, 차세대 의학연구 검색엔진 ‘이비스’ 개발 | 2023-03-30 |
54 | 의료정보 | 분당서울대 연구팀, 차세대 의학연구 검색엔진 개발 | 2023-03-30 |
53 | 후생신보 | 차세대 의학연구 검색엔진 ‘이비스’ 본격 서비스 | 2023-03-30 |
52 | 헤럴드경제 | 차세대 의학연구 검색엔진 '이비스(EEEVis)' 개발 | 2023-03-30 |
51 | 헬스경향 | 사용자 중심 차세대 의학문헌 검색엔진 나왔다 | 2023-03-30 |